Prevalence of microsatellite instability in gastric and gastroesophageal junction cancer patients from a Latin American country
Prior studies report 22% MSI phenotype prevalence in gastric tumors, mostly in developed countries, excluding Hispanic/Latino populations. Identifying the prevalence of MSI in our population as 12.26% could pave the way for approving immune blockade drugs as a treatment option for these patients in Latin American countries. Our data could be utilized to conduct cost-utility studies in support of this.
Authors
- Gabriela Negrete-Tobar (ORCID: https://orcid.org/0000-0001-5840-4946)
- Alejandro González-Motta (ORCID: https://orcid.org/0000-0003-0990-0657)
- Juliana Pineda-Ortega (ORCID: https://orcid.org/0000-0003-1752-3804)
- Oscar Alberto Messa-Botero (ORCID: https://orcid.org/0000-0001-7982-4552)
- Isabella Garciandía
- Natalia LondonÓo-De Vivero
- Ricardo Bruges-Maya
Institutions
- Pontificia Universidad Javeriana (CO)
- Centro Científico Tecnológico - San Luis (AR)
- Hospital Universitario San Ignacio (CO)
Publication Details
- Journal
- Gaceta Médica de México
- Published
- 2024-12-27
- DOI
- https://doi.org/10.24875/gmm.24000128
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00